Biotech

All Articles

GSK's long-acting bronchial asthma drug halved attacks in phase 3

.GSK's long-acting bronchial asthma treatment has actually been presented to cut in half the variety...

AstraZeneca, Daiichi unload Dato-DXd's total survival fall short

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually fallen s...

Roivant unveils brand-new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back along with a new 'vant' business, after the Roivant Sciences CEO paid f...

Viridian eye condition phase 3 smash hits, accelerating push to competing Amgen

.Viridian Therapeutics' stage 3 thyroid eye health condition (TED) scientific test has reached its k...

Bain introduces $3B fund for life scientific research firms

.With a sturdy performance history for recognizing rough diamonds, Bain Funds Lifespan Sciences (BCL...

Genentech's cancer cells restructure brought in 'for scientific causes'

.The latest selection to merge Genentech's pair of cancer cells teams was created "scientific causes...

Tern oral GLP-1 shows 5% weight management at 1 month at highest dosage

.Terns Pharmaceuticals' choice to lose its own liver illness passions might yet pay off, after the b...

Merck, Daiichi repeat early excellence in little tissue lung cancer along with upgraded ADC information

.Merck &amp Co.'s long-running initiative to land a hit on small tissue lung cancer cells (SCLC) has...

Boehringer, Bayer advance bronchi cancer drugs toward Astra fight

.Some individuals with non-small cell lung cancer cells (NSCLC) possess mutations in a genetics call...

MBX pursues $136M IPO to take opponent to Ascendis into phase 3

.MBX has actually expanded programs to consume over $136 million coming from its own IPO as the biot...